Thread: Lexicon Completes Phase 1 Clinical Trial and Initiates  |
|||||||||||||
|
Started 2 months, 3 weeks ago by surf1944
Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical
Trial of LX4211 in Patients With Type 2 Diabetes - Lexicon's Fourth Drug
Candidate in Phase 2 Development - Oral Drug Candidate Inhibits SGLT2, a
Potential Target for Diabetes - Phase 1 Results Support Once Daily Dosing
in Patients with Type 2 Diabetes Press Release Source: Lexicon
Pharmaceuticals, Inc. On Tuesday September ...
|
|
||||||||||||
|
|||||||||||||
Related threads on "Investors Hub - Discussion Groups": |
Related threads on other sites: |
||||||||||||
Thread profile page for "Lexicon Completes Phase 1 Clinical Trial and Initiates" on http://investorshub.advfn.com.
This report page is a snippet summary view from a single thread "Lexicon Completes Phase 1 Clinical Trial and Initiates", located on the Message Board at http://investorshub.advfn.com.
This thread profile page shows the thread statistics for: Total Authors, Total Thread Posts, and Thread Activity
Home |
About Us |
Submit Your Site |
Update Your Site |
Get Search For Your Site |
Partners |
Contact |
Search Plugin |
Blog |
 |
Last Searches | Top Searches |
Designated brands and trademarks are property of their respective owners.
Use of this website constitutes acceptance of BoardReader's User Agreement and Privacy Policy.